68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma: Comparison With 18F-FDG. (November 2017)

• Record Type: Journal Article
• Authors: Derlin, Thorsten; Hueper, Katja; Soudah, Bisharah
• Is Part Of: Clinical nuclear medicine. Volume 42:Number 11(2017)
• Publication Date: 2017-11
• Subjects: 18F-FDG -- hemangioendothelioma -- metastases -- octreotide -- PET/CT -- somatostatin receptor; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000001814
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: Epithelioid hemangioendothelioma (EHE) is a rare tumor originating from vascular endothelial or pre-endothelial cells. It has the potential to metastasize. We present the case of a 51-year-old woman with metastasizing EHE who underwent both 18 F-FDG and 68 Ga-DOTA-TATE PET/CT for staging of disease and for evaluation of targeted radionuclide therapy potential. On 68 Ga-DOTA-TATE PET scans, intense tracer accumulation was observed in metastases. Besides the increased glucose metabolism in EHE, this case highlights the potential of 68 Ga-DOTA-TATE PET/CT for restaging of EHE and the option of targeted radionuclide therapy in this entity.